KMPharmaceutical controlling shareholder Kang Il Mo cuts pledged stake to 16.96% in disclosure update

• KMPharmaceutical’s controlling shareholder Kang Il Mo kept voting rights unchanged at 3,220,994 shares, or 49.66%, as of Oct. 8.
• Shares pledged under major contracts fell to 1,100,000 shares, or 16.96%, from 1,194,503 shares, or 18.42%.
• The change followed partial repayment of a stock-backed loan, with the reportable event dated Sept. 30.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KMPharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008000550), on October 08, 2026, and is solely responsible for the information contained therein.